Dyax obtains FDA complete response letter for hereditary ... - Trading Markets (press release)
2009-03-30 22:26:21

Dyax obtains FDA complete response letter for hereditary ... Trading Markets (press release), CA ... a complete response letter from the FDA pertaining to the company's biologic license application for DX-88 for the treatment of acute attacks of hereditary angioedema. The letter outlines requirements for approval of DX-88 in this indication. ... Dyax cuts 60 jobs; sees Q1 charge Reuters Dyax trims pipeline, cuts 60 jobs to focus on DX-88 Mass High Tech all 28 news articles